NablavsAbridge

Nabla and Abridge are both ambient AI scribes that listen to clinical visits and draft notes. Abridge is the enterprise leader, deployed across large US health systems with deep Epic integration. Nabla is self-serve: an individual clinician can sign up, try a free tier, and pay per seat.

At a glance

NablaAbridge
CategoryProductivityProductivity
FunctionClinical scribeClinical scribe
PricingFreemiumPaid
Starting priceFree tier (limited encounters); Pro from $119/mo per clinicianEnterprise pricing (health systems); no self-serve tier
ReleasedMarch 2023January 2018

Nabla

Pros

  • Self-serve — a solo clinician can start today
  • Free tier to evaluate
  • Fast, clean notes with editable templates

Cons

  • Deep EHR integration only on higher plans
  • Less enterprise scale than Abridge
  • Price per seat is significant for small practices

Abridge

Pros

  • Widely deployed at scale — a proven, not experimental, product
  • Evidence links make notes auditable
  • Strongest EHR integration in the category

Cons

  • Not available to individual clinicians
  • Enterprise sales cycle
  • Accuracy on rare conditions still needs clinician review

Which one should you pick?

Pick Nabla if

You are an independent clinician or small practice, want to evaluate ambient scribing without an enterprise contract, or work mainly in the browser and on mobile.

See Nabla details →

Pick Abridge if

You are a health system on Epic, need auditable evidence links from note to transcript, and are buying through procurement with security review.

See Abridge details →

Bottom line

Nabla for individuals and small practices. Abridge for health systems. The technology is similar; the difference is how you buy it and how deeply it plugs into your EHR.